Phase II study of a HER-2/neu Peptide-Based Vaccine plus Concurrent Trastuzumab for Prevention of Breast Cancer Relapse

Posters
2008
TVG Cancer Vaccines
Salazar LG, Higgins D, Childs J, Bolding M, Wallace D, Dang Y, Fintak PA, Waisman JR, and Disis ML